These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38176674)

  • 1. Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer.
    Mao-Mao ; Zhang JJ; Xu YP; Shao MM; Wang MC
    Drug Discov Today; 2024 Feb; 29(2):103875. PubMed ID: 38176674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A modification: recent advances, anticancer targeted drug discovery and beyond.
    Deng LJ; Deng WQ; Fan SR; Chen MF; Qi M; Lyu WY; Qi Q; Tiwari AK; Chen JX; Zhang DM; Chen ZS
    Mol Cancer; 2022 Feb; 21(1):52. PubMed ID: 35164788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
    Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
    Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance.
    Jo H; Shim K; Jeoung D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
    Liang Z; Kidwell RL; Deng H; Xie Q
    Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
    Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress of N6-methyladenosine in colorectal cancer: A review.
    Lin Y; Shi H; Wu L; Ge L; Ma Z
    Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine functions and its role in skin cancer.
    Ran Y; Yan Z; Jiang B; Liang P
    Exp Dermatol; 2023 Jan; 32(1):4-12. PubMed ID: 36314059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA m6A methylation regulators in ovarian cancer.
    Guo J; Zheng J; Zhang H; Tong J
    Cancer Cell Int; 2021 Nov; 21(1):609. PubMed ID: 34794452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
    Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
    Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
    Han J; Kong H; Wang X; Zhang XA
    Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.
    Xu Z; Peng B; Cai Y; Wu G; Huang J; Gao M; Guo G; Zeng S; Gong Z; Yan Y
    Biochem Pharmacol; 2020 Dec; 182():114258. PubMed ID: 33017575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.
    Qiao H; Liu L; Chen J; Shang B; Wang L
    Med Oncol; 2022 Sep; 39(12):235. PubMed ID: 36175777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.
    Zhang Z; Wei W; Wang H; Dong J
    Front Oncol; 2021; 11():743990. PubMed ID: 34722298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
    Chen M; Wong CM
    Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.